The company is developing a targeted radiopharmaceutical cancer treatment called Oncocidia. This innovative treatment involves extending the already successful use of Iodine-131 in treating thyroid cancer to treat solid cancers (primary and metastatic) elsewhere in the body. Iodine-131 is used to label the necrosis avid agent hypericin. Hypericin targets necrosis in a tumor and carries …

MVision AI provides is a cloud-based software service provider for radiotherapy treatment planning. Its AI-powered automatic segmentation tool helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow. MVision’s deep learning model produces consistent contouring in minutes while maintaining the highest standards of quality for every patient, every time. As of …